These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 18456254

  • 1. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
    Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):281-4. PubMed ID: 18456254
    [Abstract] [Full Text] [Related]

  • 2. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T, Takeuchi A, Hirata T, Keto Y, Akuzawa S, Sasamata M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):190-5. PubMed ID: 17658508
    [Abstract] [Full Text] [Related]

  • 3. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.
    Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K.
    Neurogastroenterol Motil; 2008 May 14; 20(5):557-65. PubMed ID: 18221252
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
    Hirata T, Funatsu T, Keto Y, Nakata M, Sasamata M.
    Inflammopharmacology; 2007 Feb 14; 15(1):5-9. PubMed ID: 17323187
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
    Hirata T, Keto Y, Funatsu T, Akuzawa S, Sasamata M.
    J Pharmacol Sci; 2007 Jul 14; 104(3):263-73. PubMed ID: 17652911
    [Abstract] [Full Text] [Related]

  • 6. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.
    Ataka K, Kuge T, Fujino K, Takahashi T, Fujimiya M.
    Auton Neurosci; 2007 May 30; 133(2):136-45. PubMed ID: 17182287
    [Abstract] [Full Text] [Related]

  • 7. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.
    Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr 30; 292(4):G1037-44. PubMed ID: 17158256
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats.
    Hirata T, Keto Y, Yamano M, Yokoyama T, Sengoku T, Seki N.
    J Gastroenterol Hepatol; 2012 Sep 30; 27(9):1505-11. PubMed ID: 22554268
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Hirata T, Funatsu T, Keto Y, Akuzawa S, Sasamata M, Miyata K.
    J Pharmacol Sci; 2008 Feb 30; 106(2):264-70. PubMed ID: 18296863
    [Abstract] [Full Text] [Related]

  • 10. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
    Ito C, Isobe Y, Kawamura R, Kiuchi Y, Tsuchida K, Higuchi S.
    J Pharmacol Exp Ther; 1997 Jan 30; 280(1):67-72. PubMed ID: 8996183
    [Abstract] [Full Text] [Related]

  • 11. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon.
    Kimura T, Amano T, Uehara H, Ariga H, Ishida T, Torii A, Tajiri H, Matsueda K, Yamato S.
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct 30; 293(4):G903-10. PubMed ID: 17717045
    [Abstract] [Full Text] [Related]

  • 12. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y, Kontoh A, Tokita K, Tomoi M, Shimomura K, Kadowaki M.
    J Pharmacol Exp Ther; 1997 Apr 30; 281(1):284-90. PubMed ID: 9103508
    [Abstract] [Full Text] [Related]

  • 13. A dual role of 5-hydroxytryptamine receptor 3 in serotonin induced ion transport in rat distal colon.
    Yang N, Tian YM, Zhang XH, Zheng LF, Xue H, Chen X, Zhu L, Zhu JX.
    Eur J Pharmacol; 2008 Apr 14; 584(1):137-43. PubMed ID: 18313044
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of oxytocin on accelerated colonic motility induced by water-avoidance stress in rats.
    Matsunaga M, Konagaya T, Nogimori T, Yoneda M, Kasugai K, Ohira H, Kaneko H.
    Neurogastroenterol Motil; 2009 Aug 14; 21(8):856-e59. PubMed ID: 19298230
    [Abstract] [Full Text] [Related]

  • 15. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T, Minami M, Kitamura N, Teramoto Y, Ogawa T, Nemoto M, Hamaue N, Hirafuji M, Yasuda E, Blower PR.
    Res Commun Mol Pathol Pharmacol; 1999 Aug 14; 104(2):145-55. PubMed ID: 10634307
    [Abstract] [Full Text] [Related]

  • 16. Melatonin attenuates stress-induced defecation: lesson from a rat model of stress-induced gut dysfunction.
    Song GH, Gwee KA, Moochhala SM, Ho KY.
    Neurogastroenterol Motil; 2005 Oct 14; 17(5):744-50. PubMed ID: 16185314
    [Abstract] [Full Text] [Related]

  • 17. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats.
    Miyata K, Ito H, Fukudo S.
    Am J Physiol; 1998 May 14; 274(5):G827-31. PubMed ID: 9612262
    [Abstract] [Full Text] [Related]

  • 18. Comparison between partial agonist (ME3412) and antagonist (alosetron) of 5-hydroxytryptamine 3 receptor on gastrointestinal function.
    Kawano K, Mori T, Fu L, Ito T, Niisato T, Yoshida S, Shiokawa S, Sato Y, Murakami H, Shishikura T.
    Neurogastroenterol Motil; 2005 Apr 14; 17(2):290-301. PubMed ID: 15787949
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice.
    Barone FC, Barton ME, White RF, Legos JJ, Kikkawa H, Shimamura M, Kuratani K, Kinoshita M.
    Pharmacology; 2008 Apr 14; 81(1):11-7. PubMed ID: 17726343
    [Abstract] [Full Text] [Related]

  • 20. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
    Maillot C, Million M, Wei JY, Gauthier A, Taché Y.
    Gastroenterology; 2000 Dec 14; 119(6):1569-79. PubMed ID: 11113078
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.